World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders.
Bandelow B, Allgulander C, Baldwin DS, Costa DLDC, Denys D, Dilbaz N, Domschke K, Eriksson E, Fineberg NA, Hättenschwiler J, Hollander E, Kaiya H, Karavaeva T, Kasper S, Katzman M, Kim YK, Inoue T, Lim L, Masdrakis V, Menchón JM, Miguel EC, Möller HJ, Nardi AE, Pallanti S, Perna G, Rujescu D, Starcevic V, Stein DJ, Tsai SJ, Van Ameringen M, Vasileva A, Wang Z, Zohar J.
Virtual reality in the diagnostic and therapy for mental disorders: A systematic review.
Wiebe A, Kannen K, Selaskowski B, Mehren A, Thöne AK, Pramme L, Blumenthal N, Li M, Asché L, Jonas S, Bey K, Schulze M, Steffens M, Pensel MC, Guth M, Rohlfsen F, Ekhlas M, Lügering H, Fileccia H, Pakos J, Lux S, Philipsen A, Braun N.
The role of rumination in depressive disorders and mixed anxiety/depressive symptoms.
Nolen-Hoeksema S.
J Abnorm Psychol. 2000 Aug;109(3):504-11.
PMID:11016119
Putative Antidepressant Effect of Chamomile (Matricaria chamomilla L.) Oral Extract in Subjects with Comorbid Generalized Anxiety Disorder and Depression.
Modifiable risk and protective factors for anxiety disorders among adults: A systematic review.
Zimmermann M, Chong AK, Vechiu C, Papa A.
Psychiatry Res. 2020 Mar;285:112705. doi: 10.1016/j.psychres.2019.112705. Epub 2019 Dec 4.
PMID:31839417
Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
Jakubovski E, Johnson JA, Nasir M, Müller-Vahl K, Bloch MH.
Depress Anxiety. 2019 Mar;36(3):198-212. doi: 10.1002/da.22854. Epub 2018 Nov 26.
PMID:30479005
ICD-11 'mixed depressive and anxiety disorder' is clinical rather than sub-clinical and more common than anxiety and depression in the general population.
Shevlin M, Hyland P, Nolan E, Owczarek M, Ben-Ezra M, Karatzias T.